Lantern Non Currrent Assets Other vs Net Tangible Assets Analysis

LTRN Stock  USD 3.08  0.13  4.41%   
Lantern Pharma financial indicator trend analysis is infinitely more than just investigating Lantern Pharma recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lantern Pharma is a good investment. Please check the relationship between Lantern Pharma Non Currrent Assets Other and its Net Tangible Assets accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lantern Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Lantern Stock, please use our How to Invest in Lantern Pharma guide.

Non Currrent Assets Other vs Net Tangible Assets

Non Currrent Assets Other vs Net Tangible Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Lantern Pharma Non Currrent Assets Other account and Net Tangible Assets. At this time, the significance of the direction appears to have no relationship.
The correlation between Lantern Pharma's Non Currrent Assets Other and Net Tangible Assets is 0.02. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Net Tangible Assets in the same time period over historical financial statements of Lantern Pharma, assuming nothing else is changed. The correlation between historical values of Lantern Pharma's Non Currrent Assets Other and Net Tangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Lantern Pharma are associated (or correlated) with its Net Tangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Tangible Assets has no effect on the direction of Non Currrent Assets Other i.e., Lantern Pharma's Non Currrent Assets Other and Net Tangible Assets go up and down completely randomly.

Correlation Coefficient

0.02
Relationship DirectionPositive 
Relationship StrengthInsignificant

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.
Most indicators from Lantern Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lantern Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lantern Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Lantern Stock, please use our How to Invest in Lantern Pharma guide.As of the 23rd of November 2024, Selling General Administrative is likely to drop to about 4.2 M. Issuance Of Capital Stock is expected to grow at the current pace this year

Lantern Pharma fundamental ratios Correlations

0.760.921.00.980.79-0.99-0.790.620.990.80.031.0-0.890.950.920.970.931.01.0-0.881.0-0.890.860.390.83
0.760.940.750.850.81-0.65-0.860.750.650.46-0.190.76-0.630.910.840.860.940.750.76-0.640.75-0.630.530.030.78
0.920.940.920.950.82-0.85-0.880.720.850.59-0.110.92-0.80.990.920.971.00.920.92-0.80.92-0.80.680.140.9
1.00.750.920.980.79-0.99-0.780.610.990.80.031.0-0.890.950.910.970.921.01.0-0.881.0-0.890.870.390.82
0.980.850.950.980.84-0.94-0.840.690.940.760.020.98-0.890.970.930.990.960.980.98-0.880.98-0.890.810.310.83
0.790.810.820.790.84-0.73-0.930.930.740.670.030.79-0.80.870.940.850.830.790.79-0.780.79-0.80.690.140.67
-0.99-0.65-0.85-0.99-0.94-0.730.71-0.53-1.0-0.82-0.07-0.990.89-0.89-0.86-0.93-0.86-0.99-0.990.87-0.990.89-0.88-0.45-0.77
-0.79-0.86-0.88-0.78-0.84-0.930.71-0.96-0.72-0.45-0.08-0.780.85-0.89-0.96-0.88-0.89-0.78-0.790.83-0.780.84-0.510.15-0.86
0.620.750.720.610.690.93-0.53-0.960.540.380.170.61-0.740.750.880.730.730.610.62-0.710.61-0.740.39-0.230.68
0.990.650.850.990.940.74-1.0-0.720.540.820.070.99-0.890.90.870.930.860.990.99-0.880.99-0.890.880.450.78
0.80.460.590.80.760.67-0.82-0.450.380.820.130.8-0.610.690.650.70.60.80.79-0.570.8-0.610.980.790.33
0.03-0.19-0.110.030.020.03-0.07-0.080.170.070.130.03-0.18-0.040.060.04-0.090.030.03-0.010.03-0.190.0-0.10.03
1.00.760.921.00.980.79-0.99-0.780.610.990.80.03-0.890.950.910.970.931.01.0-0.881.0-0.890.870.390.82
-0.89-0.63-0.8-0.89-0.89-0.80.890.85-0.74-0.89-0.61-0.18-0.89-0.83-0.91-0.91-0.82-0.89-0.890.98-0.891.0-0.66-0.08-0.83
0.950.910.990.950.970.87-0.89-0.890.750.90.69-0.040.95-0.830.950.980.990.950.95-0.820.95-0.830.760.230.87
0.920.840.920.910.930.94-0.86-0.960.880.870.650.060.91-0.910.950.960.930.910.92-0.90.91-0.910.70.090.86
0.970.860.970.970.990.85-0.93-0.880.730.930.70.040.97-0.910.980.960.980.970.97-0.890.97-0.910.760.220.89
0.930.941.00.920.960.83-0.86-0.890.730.860.6-0.090.93-0.820.990.930.980.920.93-0.820.93-0.820.690.140.9
1.00.750.921.00.980.79-0.99-0.780.610.990.80.031.0-0.890.950.910.970.921.0-0.881.0-0.890.870.390.82
1.00.760.921.00.980.79-0.99-0.790.620.990.790.031.0-0.890.950.920.970.931.0-0.881.0-0.890.860.380.83
-0.88-0.64-0.8-0.88-0.88-0.780.870.83-0.71-0.88-0.57-0.01-0.880.98-0.82-0.9-0.89-0.82-0.88-0.88-0.880.98-0.65-0.09-0.82
1.00.750.921.00.980.79-0.99-0.780.610.990.80.031.0-0.890.950.910.970.931.01.0-0.88-0.890.860.390.82
-0.89-0.63-0.8-0.89-0.89-0.80.890.84-0.74-0.89-0.61-0.19-0.891.0-0.83-0.91-0.91-0.82-0.89-0.890.98-0.89-0.66-0.09-0.83
0.860.530.680.870.810.69-0.88-0.510.390.880.980.00.87-0.660.760.70.760.690.870.86-0.650.86-0.660.770.43
0.390.030.140.390.310.14-0.450.15-0.230.450.79-0.10.39-0.080.230.090.220.140.390.38-0.090.39-0.090.77-0.17
0.830.780.90.820.830.67-0.77-0.860.680.780.330.030.82-0.830.870.860.890.90.820.83-0.820.82-0.830.43-0.17
Click cells to compare fundamentals

Lantern Pharma Account Relationship Matchups

Lantern Pharma fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.4M20.4M74.0M58.8M43.6M36.4M
Other Current Liab489.3K120K1.5M1.8M2.5M1.3M
Total Current Liabilities489.3K552.3K2.3M2.8M2.7M1.7M
Total Stockholder Equity943.3K19.7M71.6M56.0M40.9M34.6M
Net Tangible Assets943.0K19.7M71.6M56.0M64.4M32.6M
Property Plant And Equipment Net8.8K21.5K216.2K95.7K280.4K294.4K
Net Debt(1.2M)(19.1M)(51.3M)(37.1M)(21.7M)(22.8M)
Retained Earnings(6.8M)(12.7M)(25.0M)(39.3M)(55.2M)(52.5M)
Accounts Payable489.3K432.3K681.1K932.4K2.5M2.6M
Cash1.2M19.2M51.5M37.2M21.9M24.1M
Non Current Assets Total199.8K122.7K1.2M113.6K306.3K363.2K
Cash And Short Term Investments1.2M19.2M70.7M55.2M41.3M34.5M
Common Stock Shares Outstanding6.3M6.2M10.9M10.9M10.8M9.4M
Liabilities And Stockholders Equity1.4M20.4M74.0M58.8M43.6M36.4M
Other Stockholder Equity7.7M32.4M96.7M95.7M96.3M61.0M
Total Liab489.3K660.8K2.4M2.8M2.7M1.8M
Net Invested Capital929.3K19.8M71.6M56.0M40.9M34.7M
Total Current Assets1.2M20.2M72.7M58.7M43.3M36.1M
Capital Stock25.4K622.01.1K1.1K1.1K1.0K
Net Working Capital743.5K19.7M70.4M55.9M40.7M34.3M
Property Plant Equipment8.8K21.5K216.2K48.0K55.2K65.8K

Pair Trading with Lantern Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lantern Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lantern Pharma will appreciate offsetting losses from the drop in the long position's value.

Moving together with Lantern Stock

  0.69ME 23Andme HoldingPairCorr
  0.68VALN Valneva SE ADRPairCorr

Moving against Lantern Stock

  0.49KZR Kezar Life SciencesPairCorr
  0.41MLYS Mineralys Therapeutics,PairCorr
  0.4NXGLW NexGel WarrantPairCorr
The ability to find closely correlated positions to Lantern Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lantern Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lantern Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lantern Pharma to buy it.
The correlation of Lantern Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lantern Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lantern Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lantern Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Lantern Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lantern Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lantern Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lantern Pharma Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lantern Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Lantern Stock, please use our How to Invest in Lantern Pharma guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lantern Pharma. If investors know Lantern will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lantern Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.78)
Return On Assets
(0.28)
Return On Equity
(0.45)
The market value of Lantern Pharma is measured differently than its book value, which is the value of Lantern that is recorded on the company's balance sheet. Investors also form their own opinion of Lantern Pharma's value that differs from its market value or its book value, called intrinsic value, which is Lantern Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lantern Pharma's market value can be influenced by many factors that don't directly affect Lantern Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lantern Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lantern Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lantern Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.